3:30 PM - *
(Cancer) Theranostics with (Intrinsically) Radiolabeled Nanomaterials
Weibo Cai1
University of Wisconsin--Madison1
Show Abstract
Radiolabeled nanomaterials have gained tremendous interest over the last 2 decades, which can play diverse roles in imaging, image-guided drug delivery, as well as theranostics of a number of diseases such as cancer. Some recent examples of radiolabeled materials from our recent work will be briefly described in this talk.
Although chelator-based radiolabeling techniques (commonly used for labeling nanomaterials with radiometals such as 64Cu/89Zr) have been used for decades, concerns about the complexity of coordination chemistry, possible alteration of nanomaterial pharmacokinetics, and potential detachment of radioisotopes have driven the need for developing a simpler yet better technique for future radiolabeling, which may facilitate future clinical translation.
The emerging area of intrinsically radiolabeled nanomaterials can take advantage of the unique physical and chemical properties of well-selected inorganic or organic nanomaterials for radiolabeling, and more importantly, offer an easier, faster, and more specific radiolabeling possibility to facilitate future clinical translation. Generally speaking, the four major categories of intrinsically radiolabeled nanomaterials include: 1) hot-plus-cold precursors, 2) specific trapping, 3) cation exchange, and 4) proton beam activation.
Representative examples of these strategies will be briefly illustrated in this talk, with the main focus on our own work that involves the radiolabeling of a variety of nanomaterials via “specific trapping”. The nanomaterials investigated in our laboratory include silica/carbon-based nanomaterials, COVID-19 nano-vaccines, multifunctional/multimodal hybrid nanomaterials, iron oxide nanoparticles, micelles, DNA nanostructures, etc. [1-10].
References
1. Goel S, Ferreira CA, Chen F, Ellison PA, Siamof CM, Barnhart TE, Cai W. Advanced Materials, 2018, 30, 1704367. (PMCID: PMC5805572)
2. Ni D, Jiang D, Ehlerding EB, Huang P, Cai W. Accounts of Chemical Research, 2018, 51, 778-788. (PMCID: PMC5878690)
3. Jiang D, Ge Z, Im H-J, England CG, Ni D, Hou J, Zhang L, Kutyreff CJ, Yan Y, Liu Y, Cho SY, Engle JW, Shi J, Huang P, Fan C, Yan H, Cai W. Nature Biomedical Engineering, 2018, 2, 865-877. (PMCID: PMC6258029)
4. Ni D, Ferreira CA, Barnhart TE, Quach V, Yu B, Jiang D, Wei W, Liu H, Engle JW, Hu P, Cai W. Journal of the American Chemical Society, 2018, 140, 14971-14979. (PMCID: PMC6310174)
5. Ni D, Ehlerding EB, Cai W. Angewandte Chemie International Edition, 2019, 58, 2570-2579. (PMCID: PMC6314921)
6. Ferreira CA, Ni D, Rosenkrans ZT, Cai W. Angewandte Chemie International Edition, 2019, 58, 13232-13252. (PMCID: PMC6698437)
7. Ni D, Wei H, Chen W, Bao Q, Rosenkrans ZT, Barnhart TE, Ferreira CA, Wang Y, Yao H, Sun T, Jiang D, Li S, Cao T, Liu Z, Engle JW, Hu P, Lan X, Cai W. Advanced Materials, 2019, 31, 1902956. (PMCID: PMC6773480)
8. Jiang D, Rosenkrans ZT, Ni D, Lin J, Huang P, Cai W. Accounts of Chemical Research, 2020, 53, 1869-1880. (PMCID: PMC7494607)
9. Wang H, Guo J, Lin W, Fu Z, Ji X, Yu B, Lu M, Cui W, Deng L, Engle JW, Wu Z, Cai W, Ni D. Advanced Materials, 2022, 34, 2110283. (PMCID: PMC9012683)
10. Li S, Wang Y, Wu M, Younis MH, Engle JW, Zhu X, Cai W. Advanced Materials, 2022, 34, e22049763. (PMID: 35973230)